HBEGF and Alzheimer disease: The conflicting literature on HB-EGF, as a neuroprotective factor, and the neurotoxicity associated with the receptors EGFR/ErbB further stresses the need of novel model systems to investigate these pathways in more depths and their therapeutic potential for AD treatment.